Skip to content

Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071214/

From 2018, this study reviewed the data regarding HD Vitamin C in cancer care to date and found that there is evidence that the use of HD Vitamin C leads to tumor regression and improved survival outcomes.

Based on the research, the authors conclude that HD Vitamin C is safe as both a standalone treatment or in conjunction with chemotherapy and that patients taking HD Vitamin C generally experienced an improved quality of life.

Share on facebook
Share on email
Share on twitter
Share on linkedin

More on HD Vitamin C

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments